Pacer Advisors
INO icon

Pacer Advisors’s Inovio Pharmaceuticals INO Stock Holding History

Pacer Advisors’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-619
Closed -$69K – 1474
2021
Q1 		$69K Sell
619
-378
-38% -$49.7K ﹤0.01% 1381
2020
Q4 		$106K Buy
997
+324
+48% +$43.1K ﹤0.01% 1359
2020
Q3 		$94K Buy
+673
New +$140K ﹤0.01% 1257
2018
Q4 		– Sell
-747
Closed -$50K – 787
2018
Q3 		$50K Buy
+747
New +$41.6K ﹤0.01% 1141
2018
Q1 		– Sell
-288
Closed -$14K – 1083
2017
Q4 		$14K Buy
+288
New +$17.9K ﹤0.01% 1122

Other funds holding INO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Pacer Advisors's INO Position: Q2 2021 in Review

Pacer Advisors sold out of Inovio Pharmaceuticals (INO) in Q2 2021, closing a stake of 619 shares — an estimated $69K sold.

Pacer Advisors first reported a position in INO in Q4 2017 and held it in 5 quarters. The position peaked at $106K in Q4 2020. 211 funds tracked by Wall St. Rank hold INO as of Q2 2021.

  • Pacer Advisors reported no remaining Inovio Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Pacer Advisors sold 619 Inovio Pharmaceuticals shares in Q2 2021, an estimated $69K.
  • Pacer Advisors first reported a position in Inovio Pharmaceuticals in Q4 2017 and held it in 5 quarters.
  • Pacer Advisors's Inovio Pharmaceuticals position peaked at $106K in Q4 2020.
  • 211 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2021.

Based on Pacer Advisors's 13F filing for Q2 2021, filed 21 Jul 2021.